Human embryonic stem cell lines: the ethics of derivation

Area of Science:

• Reproductive Medicine and Biology
• Stem Cell Research Ethics
• Canadian Bioethics Policy

Background:

• Stem cell research in Canada utilizes human embryos created via in vitro fertilization (IVF).
• Current regulations permit research on excess IVF embryos if created for infertility treatment, no longer needed, and with consent.
• These excess embryos represent a valuable yet scarce resource for deriving embryonic stem cell lines.

Purpose of the Study:

• To highlight the scarcity of excess human embryos available for stem cell research in Canada.
• To advocate for the development of sound, timely, and coordinated policies for their use.
• To prevent the injudicious use of these embryos in less critical research or when alternatives exist.

Main Methods:

• Policy analysis of existing Canadian regulations on human embryo research.
• Ethical considerations regarding resource allocation in scientific research.
• Review of potential consequences of inadequate embryo utilization policies.

Main Results:

• Excess IVF human embryos are a limited resource, not an abundant one.
• Injudicious use risks hindering domestic stem cell line derivation.
• Inadequate policies may lead to reliance on imported stem cell lines and pressure to alter research regulations.

Conclusions:

• Urgent need for robust policies governing the use of scarce excess IVF embryos for stem cell research.
• Judicious allocation is crucial to maximize scientific benefit and maintain ethical standards.
• Failure to implement effective policies could jeopardize Canada's stem cell research capacity and independence.